Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma
- 13 February 2003
- journal article
- clinical trial
- Published by Springer Nature in Psychopharmacology
- Vol. 166 (3) , 264-270
Abstract
The cardiovascular effects of psychostimulant drugs (methylphenidate, amphetamine, cocaine) have been mostly associated with their noradrenergic effects. However, there is some evidence that dopaminergic effects are involved in the cardiovascular actions of these drugs. Here, we evaluated this association in humans.Keywords
This publication has 43 references indexed in Scilit:
- Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious ratsBritish Journal of Pharmacology, 2000
- PRESSOR RESPONSES TO BRAIN DOPAMINERGIC STIMULATIONClinical and Experimental Pharmacology and Physiology, 1997
- Possible novel pharmacodynamic action of cocaine: Cardiovascular and behavioral evidencePharmacology Biochemistry and Behavior, 1996
- Effects of Blood Flow on [ 11 C]Raclopride Binding in the Brain: Model Simulations and Kinetic Analysis of PET DataJournal of Cerebral Blood Flow & Metabolism, 1994
- Imaging endogenous dopamine competition with [11C]raclopride in the human brainSynapse, 1994
- Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levelsSynapse, 1993
- Effects of Stimulant Medication on Learning in Children with ADHDJournal of Learning Disabilities, 1991
- Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1990
- Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brainSynapse, 1989
- Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjectsLife Sciences, 1984